Nuveen, LLC Chroma Dex Corp. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Nuveen, LLC holds 66,114 shares of CDXC stock, worth $405,939. This represents 0.0% of its overall portfolio holdings.
Number of Shares
66,114Holding current value
$405,939% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CDXC
# of Institutions
138Shares Held
22.7MCall Options Held
203KPut Options Held
23.9K-
Vanguard Group Inc Valley Forge, PA3.54MShares$21.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$19.1 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA1.99MShares$12.2 Million6.26% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$7.96 Million0.14% of portfolio
-
Geode Capital Management, LLC Boston, MA1.15MShares$7.09 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $420M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...